Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study on AsiDNA in Association With Re-irradiation in Children, Adolescents and Young Adults With High-grade Glioma

NCT05394558 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT05394558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05394558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study on AsiDNA in Association With Re-irradiation in Children, Adolescents and Young Adults With High-grade Glioma
Lead sponsor
Institut Curie
Phase
Phase 1/2
Overall status
Terminated
Start date
May 27, 2022
Completion date
September 20, 2023
Enrollment
8 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent high-grade glioma